US egg recall highlights drug-resistant Salmonella strain posing treatment challenges

A nationwide egg recall in the US is linked to a Salmonella strain resistant to common antibiotics, complicating treatment for vulnerable patients and signalling a potential shift in outbreak management.

The most important detail in the United States egg recall may be the least visible one: the Salmonella strain linked to the outbreak appears resistant to drugs clinicians often rely on in severe cases.

According to the CDC’s 24 July update, whole-genome sequencing of samples from all 98 patients predicted nonsusceptibility to ciprofloxacin and resistance to nalidixic acid. Twenty-six people have been hospitalised. The agency says most Salmonella infections clear without antibiotics, but where treatment is needed, this outbreak may require a different choice of drug.

The FDA says 98 people across 17 states have been infected, with illnesses spanning from 21 November 2025 to 30 June 2026. Of those with exposure information, 40 of 44 reported eating eggs. Midwest Poultry Services recalled 1,589,577 dozen shell eggs on 22 July after the products, produced in Texas between 6 June and 3 July, were linked to the outbreak.

The eggs were sold under Country Morning, Cal-Maine Sunups, Brookshire’s, Simple Truth and Kroger labels. The FDA says the recalled products are a likely source, though not necessarily the only one.

For clinicians, the resistance finding matters most for older adults, young children, pregnant people and patients with weakened immune systems. For consumers, the advice remains straightforward: discard recalled eggs, clean affected surfaces, and seek medical care promptly if symptoms become severe.

"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."